Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Alterations of the bile microbiome in primary sclerosing cholangitis.

Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C.

Gut. 2019 Jun 26. pii: gutjnl-2019-318416. doi: 10.1136/gutjnl-2019-318416. [Epub ahead of print]

PMID:
31243055
2.

The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.

Torres J, Palmela C, Brito H, Bao X, Ruiqi H, Moura-Santos P, Pereira da Silva J, Oliveira A, Vieira C, Perez K, Itzkowitz SH, Colombel JF, Humbert L, Rainteau D, Cravo M, Rodrigues CM, Hu J.

United European Gastroenterol J. 2018 Feb;6(1):112-122. doi: 10.1177/2050640617708953. Epub 2017 May 5.

3.

Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.

Rupp C, Bode KA, Leopold Y, Sauer P, Gotthardt DN.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1380-1389. doi: 10.1016/j.bbadis.2017.09.012. Epub 2017 Sep 22.

4.

Duodenal EUS to identify thickening of the extrahepatic biliary tree wall in primary sclerosing cholangitis.

Mesenas S, Vu C, Doig L, Meenan J.

Gastrointest Endosc. 2006 Mar;63(3):403-8.

PMID:
16500387
5.

Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.

Kim JH, Byun JH, Kim SY, Lee SS, Kim HJ, Kim MH, Lee MG.

Acta Radiol. 2013 Jul;54(6):601-7. doi: 10.1177/0284185113481018. Epub 2013 Apr 30.

PMID:
23528564
6.

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.

Gauss A, Sauer P, Stiehl A, Rupp C, Krisam J, Leopold Y, Kloeters-Plachky P, Stremmel W, Gotthardt D.

Medicine (Baltimore). 2016 Apr;95(17):e3510. doi: 10.1097/MD.0000000000003510.

7.

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.

Pereira P, Aho V, Arola J, Boyd S, Jokelainen K, Paulin L, Auvinen P, Färkkilä M.

PLoS One. 2017 Aug 10;12(8):e0182924. doi: 10.1371/journal.pone.0182924. eCollection 2017.

8.

Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.

Zweers SJ, Shiryaev A, Komuta M, Vesterhus M, Hov JR, Perugorria MJ, de Waart DR, Chang JC, Tol S, Te Velde AA, de Jonge WJ, Banales JM, Roskams T, Beuers U, Karlsen TH, Jansen PL, Schaap FG.

Liver Int. 2016 Sep;36(9):1370-7. doi: 10.1111/liv.13092. Epub 2016 Mar 16.

PMID:
26866350
9.

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.

Sabino J, Vieira-Silva S, Machiels K, Joossens M, Falony G, Ballet V, Ferrante M, Van Assche G, Van der Merwe S, Vermeire S, Raes J.

Gut. 2016 Oct;65(10):1681-9. doi: 10.1136/gutjnl-2015-311004. Epub 2016 May 20.

10.

Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.

Gauss A, Ehehalt R, Lehmann WD, Erben G, Weiss KH, Schaefer Y, Kloeters-Plachky P, Stiehl A, Stremmel W, Sauer P, Gotthardt DN.

World J Gastroenterol. 2013 Sep 7;19(33):5454-63. doi: 10.3748/wjg.v19.i33.5454.

11.

Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.

Lankisch TO, Metzger J, Negm AA, Vosskuhl K, Schiffer E, Siwy J, Weismüller TJ, Schneider AS, Thedieck K, Baumeister R, Zürbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J.

Hepatology. 2011 Mar;53(3):875-84. doi: 10.1002/hep.24103. Epub 2011 Jan 3.

PMID:
21374660
12.

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.

Rühlemann M, Liwinski T, Heinsen FA, Bang C, Zenouzi R, Kummen M, Thingholm L, Tempel M, Lieb W, Karlsen T, Lohse A, Hov J, Denk G, Lammert F, Krawczyk M, Schramm C, Franke A.

Aliment Pharmacol Ther. 2019 Sep;50(5):580-589. doi: 10.1111/apt.15375. Epub 2019 Jun 28.

PMID:
31250469
13.

Characteristic Findings of Primary Sclerosing Cholangitis on Endoscopic Retrograde Cholangiography: Which is the Most Common Finding?

Mohammad Alizadeh AH, Shahnazi A, Rasoulzadeh A, Shams E, Mohammadi M, Darabi F, Behdad M.

Clin Med Insights Gastroenterol. 2011 Dec 20;5:1-4. doi: 10.4137/CGast.S7850. eCollection 2012.

14.

Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis--a study of bile cultures from ERCP.

Björnsson ES, Kilander AF, Olsson RG.

Hepatogastroenterology. 2000 Nov-Dec;47(36):1504-8.

PMID:
11148988
15.

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.

Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C; Saint-Antoine IBD Network, Chazouillères O, Housset C, Sokol H.

Gut. 2019 Apr 19. pii: gutjnl-2018-317791. doi: 10.1136/gutjnl-2018-317791. [Epub ahead of print]

16.

Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.

Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E, Becker C, Neurath MF, Lohse AW, Herkel J, Schramm C.

Hepatology. 2013 Sep;58(3):1084-93. doi: 10.1002/hep.26447. Epub 2013 Jul 30.

PMID:
23564624
17.

S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.

Reinhard L, Rupp C, Riedel HD, Ruppert T, Giese T, Flechtenmacher C, Weiss KH, Kloeters-Plachky P, Stremmel W, Schirmacher P, Sauer P, Gotthardt DN.

PLoS One. 2012;7(1):e29821. doi: 10.1371/journal.pone.0029821. Epub 2012 Jan 11.

18.

Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.

Tietz-Bogert PS, Kim M, Cheung A, Tabibian JH, Heimbach JK, Rosen CB, Nandakumar M, Lazaridis KN, LaRusso NF, Sung J, O'Hara SP.

Int J Mol Sci. 2018 Oct 16;19(10). pii: E3188. doi: 10.3390/ijms19103188.

19.

In vivo 1 H MRS of human gallbladder bile in understanding the pathophysiology of primary sclerosing cholangitis (PSC): Immune-mediated disease versus bile acid-induced injury.

Mohajeri S, Bezabeh T, Ijare OB, King SB, Thomas MA, Minuk G, Lipschitz J, Kirkpatrick I, Micflikier AB, Summers R, Smith ICP.

NMR Biomed. 2019 May;32(5):e4065. doi: 10.1002/nbm.4065. Epub 2019 Feb 8.

PMID:
30735273
20.

Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography.

Moff SL, Kamel IR, Eustace J, Lawler LP, Kantsevoy S, Kalloo AN, Thuluvath PJ.

Gastrointest Endosc. 2006 Aug;64(2):219-23.

PMID:
16860072

Supplemental Content

Support Center